Last updated: January 17, 2024
Sponsor: The Hong Kong Polytechnic University
Overall Status: Completed
Phase
N/A
Condition
Communication Disorders
Speech Disorders
Treatment
Sham-tDCS
Active-tDCS
Clinical Study ID
NCT05574803
HSEARS20210311001
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Demonstrated features of stuttering;
- More than 2% of syllables stuttered over three baseline speech samples, as measured byqualified speech therapists.
Exclusion
Exclusion Criteria:
- Personal or family history of epilepsy or seizures
- History of a neurological condition
- Speech disorders
- Hearing impairment
- Metallic foreign body implant
- On medications that lower neural thresholds (e.g. tricyclines, antidepressants,neuroleptic agents, etc.)
- Pregnant
- Had speech therapy for stuttering in the past four months
Study Design
Total Participants: 10
Treatment Group(s): 2
Primary Treatment: Sham-tDCS
Phase:
Study Start date:
July 27, 2021
Estimated Completion Date:
December 31, 2023
Study Description
Connect with a study center
The Hong Kong Polytechnic University
Kowloon,
Hong KongSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.